BioStem Technologies's total assets for Q3 2025 were $62.39M, a decrease of -44.59% from the previous quarter. BSEM total liabilities were $12.38M for the fiscal quarter, a -80.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.